Physician profile
Patrick Parker
NPI 1619170446
$10,986.23
in general payments reported to CMS, 2019-2025
48 companies · $715 in 2025
The $715 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,488 · 2020: $878 · 2021: $1,133 · 2022: $1,180 · 2023: $2,470 · 2024: $1,122 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,455 · Travel and Lodging: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,455.25 |
| Travel and Lodging | $851.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,371.46 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml, Lithovue |
| Procept Biorobotics Corporation | $1,627.31 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $1,035.37 | 2019-2025 | Speedicath |
| Astellas Pharma US INC | $815.40 | 2019-2024 | Myrbetriq, Veozah |
| Myriad Genetic Laboratories, INC. | $807.59 | 2021-2024 | Prolaris |
| Antares Pharma, INC. | $549.59 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $527.25 | 2019-2024 | Xiaflex |
| Pfizer INC. | $487.88 | 2019-2025 | |
| Teleflex LLC | $298.19 | 2021-2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $292.01 | 2021-2025 | |
| Neotract INC. | $213.04 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $195.91 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $179.44 | 2019-2025 | |
| Janssen Biotech, INC. | $149.69 | 2019-2024 | Akeega, Erleada, Balversa |
| Allergan, INC. | $134.34 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.